Pharma Marketing.pptx
•Download as PPTX, PDF•
0 likes•16 views
The document discusses the global and Indian pharmaceutical markets and pharmaceutical marketing. It begins by listing the top 10 pharmaceutical brands by sales value globally, led by COVID vaccines Comirnaty and Spikevax. It then notes that the global pharmaceutical market is expected to be worth $1.57 trillion by 2023 due to factors like aging populations, income growth, and new diseases. Next, it defines marketing as an exchange to satisfy needs and wants. It dispels misconceptions that marketing is just selling or advertising, or that healthcare and pharmacy professionals do not need to market. The document goes on to cover brand management and functions of a marketing department.
Report
Share
Report
Share
Recommended
Pharma Brand Management.pptx
This document discusses pharmaceutical marketing and provides information on key topics within the field. It begins by outlining the top 10 pharmaceutical brands globally by sales revenue, led by COVID vaccines Comirnaty and Spikevax. Next, it states that the global pharmaceutical market is expected to be worth $1.57 trillion by 2023 due to demographic and disease trends. It also provides an overview of the Indian pharmaceutical market. The document then defines marketing and discusses misconceptions about the field before explaining the importance of marketing for pharmacists in their various roles.
Pharmaceutical Brand Management.pptx
This document discusses pharmaceutical marketing and provides information on key topics including:
- The top 10 pharmaceutical brands by sales and the companies that produce them. The global market is worth $1.57 trillion by 2023.
- An overview of the global and Indian pharmaceutical markets, which are growing due to aging populations, rising incomes, and new diseases.
- Definitions of marketing and common misconceptions about marketing in healthcare.
- The roles and functions of marketing departments in the pharmaceutical industry, including brand management and production.
- Why marketing is important for pharmacists and how it can help them problem solve, influence others, and advance their careers.
What are the world's top selling drugs
After reviewing the top 10 oncology pharmaceutical companies 2020, now let's find the top 10 best-selling drugs in the world of 2020.
Presentation: What's trending in medicines regulation? A January 2017 reflection
This presentation provides a local perspective on recent developments in the medical technology and pharmaceutical landscape, and the future of the TGA in a global context.
Top 10 Biotech Companies & Market Share 2008
The document analyzes the biotech market in 2007-2008 and summarizes the top 10 biotech companies by sales. Amgen was the top company with $15.9 billion in sales, mainly from blockbuster drugs like Enbrel, Neulasta, and Neupogen. Roche/Genentech was second with $15.4 billion from drugs like Rituxan, Herceptin, and Avastin. The document outlines each company's current blockbuster drugs and promising new treatments in their pipelines.
Cadila Pharmaceuticals corporate presentation
Corporate presentation would provide users with basic information about our company, so you can know us better.
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Remdesivir
Gilead signed agreements with five generic drug makers in India and Pakistan to expand the supply of the investigational drug remdesivir for treating COVID-19 in 127 countries. The agreements allow Cipla Limited, Ferozsons Laboratories, Hetero Labs Ltd, Jubilant Lifesciences and Mylan to manufacture remdesivir. The global remdesivir market is segmented based on dosage, patient type, application such as COVID-19 treatment, and end user including hospitals, clinics, pharmacies and online pharmaceuticals.
Recommended
Pharma Brand Management.pptx
This document discusses pharmaceutical marketing and provides information on key topics within the field. It begins by outlining the top 10 pharmaceutical brands globally by sales revenue, led by COVID vaccines Comirnaty and Spikevax. Next, it states that the global pharmaceutical market is expected to be worth $1.57 trillion by 2023 due to demographic and disease trends. It also provides an overview of the Indian pharmaceutical market. The document then defines marketing and discusses misconceptions about the field before explaining the importance of marketing for pharmacists in their various roles.
Pharmaceutical Brand Management.pptx
This document discusses pharmaceutical marketing and provides information on key topics including:
- The top 10 pharmaceutical brands by sales and the companies that produce them. The global market is worth $1.57 trillion by 2023.
- An overview of the global and Indian pharmaceutical markets, which are growing due to aging populations, rising incomes, and new diseases.
- Definitions of marketing and common misconceptions about marketing in healthcare.
- The roles and functions of marketing departments in the pharmaceutical industry, including brand management and production.
- Why marketing is important for pharmacists and how it can help them problem solve, influence others, and advance their careers.
What are the world's top selling drugs
After reviewing the top 10 oncology pharmaceutical companies 2020, now let's find the top 10 best-selling drugs in the world of 2020.
Presentation: What's trending in medicines regulation? A January 2017 reflection
This presentation provides a local perspective on recent developments in the medical technology and pharmaceutical landscape, and the future of the TGA in a global context.
Top 10 Biotech Companies & Market Share 2008
The document analyzes the biotech market in 2007-2008 and summarizes the top 10 biotech companies by sales. Amgen was the top company with $15.9 billion in sales, mainly from blockbuster drugs like Enbrel, Neulasta, and Neupogen. Roche/Genentech was second with $15.4 billion from drugs like Rituxan, Herceptin, and Avastin. The document outlines each company's current blockbuster drugs and promising new treatments in their pipelines.
Cadila Pharmaceuticals corporate presentation
Corporate presentation would provide users with basic information about our company, so you can know us better.
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Remdesivir
Gilead signed agreements with five generic drug makers in India and Pakistan to expand the supply of the investigational drug remdesivir for treating COVID-19 in 127 countries. The agreements allow Cipla Limited, Ferozsons Laboratories, Hetero Labs Ltd, Jubilant Lifesciences and Mylan to manufacture remdesivir. The global remdesivir market is segmented based on dosage, patient type, application such as COVID-19 treatment, and end user including hospitals, clinics, pharmacies and online pharmaceuticals.
Top 10 biotech companies & market share 2008
The biotech market grew 12.5% in 2007, twice as fast as the pharmaceutical market. The top 10 biotech companies comprised $61.4 billion in sales, or over 10% of the $712 billion prescription drug market. Amgen was the largest biotech company, with $15.9 billion in sales and blockbuster drugs like Enbrel. Amgen and other top companies like Roche/Genentech, Johnson & Johnson, and Novo Nordisk have several blockbuster drugs on the market and are developing new therapies, with many awaiting FDA approval.
‘Orphan drugs’ future growth potential for indian pharmaceutical market
This document discusses orphan drugs and their potential in the Indian pharmaceutical market. It defines orphan drugs as those developed for rare diseases affecting less than 8% of the population. The US was the first to pass orphan drug legislation in 1983 to incentivize development of these drugs. Similar laws now exist in other countries and provide benefits like 7 years of market exclusivity. While initially developed for small populations, some orphan drugs like Rituxan have become very profitable blockbusters. The global orphan drug market was worth $50 billion in 2011 and is growing faster than other drug markets. Several Indian companies are now developing or manufacturing orphan drugs for rare diseases.
Pharmaceutical Marketing
The document provides an overview of the global and Indian pharmaceutical industries and pharmaceutical marketing. It discusses how pharmaceutical companies research and develop new drugs, the large market size and top companies globally and in India, India's role as a major exporter of generic drugs, and common marketing strategies used in India's prescription-driven branded generic market, which involve establishing relationships with doctors who are the key decision-makers through regular visits and promotion by marketing representatives.
Global antibody drug conjugate market & pipeline insight2020
" Global Antibody Drug Conjugate Market & Pipeline Insight 2020" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
Download Global antibody drug conjugate market & pipeline insight2020
\" Global Antibody Drug Conjugate Market & Pipeline Insight 2020\" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
GDHC118PIDR_Peripheral Artery Disease_sample
This document provides a summary and analysis of the global peripheral artery disease (PAD) drug market from 2014-2024. Some key points:
- The global PAD drug market was worth $543.4 million in 2014 and is projected to reach $816.3 million by 2024, a compound annual growth rate of 4.15%.
- The US and China are expected to experience the strongest growth in market share, while markets in the EU and Japan will remain stagnant or contract.
- Promising late-stage pipeline drugs like Xarelto, Brilinta, and Zontivity have the potential to significantly impact the market but will face competition from cheaper generics after losing exclusivity during the forecast
Cardiac Market Outlook - 2016 by Nitesh bhele
Cardiac Market Outlook - 2016 by Nitesh bhele
Nitesh Bhele - Marketer, Writer | Healthcare & Pharmaceutical Industry
India and global generics M&A Summary 2007
This document provides a summary of mergers and acquisitions (M&A) deals in the global and Indian generics industries from 2007 and an outlook for 2007-2010. It finds that the generics market is growing faster than the branded drug market. Both large non-Indian and Indian generic companies are pursuing M&A deals to gain market share and access new markets. Transaction sizes for non-Indian deals were in the hundreds of millions to billions, while Indian deals were typically in the high millions. The outlook for Indian generics companies remains strong, though profitability challenges exist from funding large deals and global integration.
Bio similar- An opportunities or challenge for Indian Company
1. The global biosimilars market is expected to grow significantly in the coming years due to various drivers such as patent expiries of major biologics and increasing cost containment pressures.
2. Indian companies are well positioned in the biosimilars space due to their established low-cost manufacturing capabilities and expertise in biologics. Key players in India include Dr. Reddy's, Biocon, Cipla and Intas.
3. Developing biosimilars presents several challenges including high development costs, complex clinical trials and unclear regulatory guidelines. Indian companies strategy involves partnerships for cost-effective development and leveraging domestic capabilities and emerging markets for growth.
Shivai Gupta - POSTER
Orphan drugs are pharmaceutical agents that treat rare diseases or conditions affecting less than 200,000 people in the United States. The Orphan Drug Act provides incentives for developing these drugs, including 7 years of market exclusivity and tax credits. Since its passage, over 3,600 orphan drugs have been designated. By 2020, orphan drugs are projected to make up 20.2% of worldwide prescription drug sales due to their high prices and lack of alternatives for patients.
Us blood cancer drug market & pipeline analysis 2015
"US Blood Cancer Drug Market & Pipeline Analysis 2015" Report Highlights:
Blood Cancer Incidence & Prevalence
Blood Cancer Drug Market Overview
Blood Cancer Drug Market Dynamics
Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline Insight
Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline: 435 Drugs
Majority Drugs in Phase-I Clinical Trials: 128 Drugs
Marketed Leukemia, Lymphoma & Myeloma Drug Clinical & Patent Analysis
Marketed Leukemia, Lymphoma & Myeloma Drug: 48 Drugs
Download Us blood cancer drug market & pipeline analysis 2015
US pharmaceutical companies have identified opportunities to generate significant revenues from treating blood cancers in the US market. The number of blood cancer cases is rising, and demand exists for improved therapies. As a result, many new drugs have been introduced for treating blood cancers. Several innovative therapies are in clinical trials that could be approved in coming years. Key drug classes for treating blood cancers include chemotherapy drugs, monoclonal antibodies, and tyrosine kinase inhibitors, which have shown better outcomes than chemotherapy alone. The future blood cancer drug market is expected to grow as more innovative therapies enter the market, though developing treatments remains challenging due to the heterogeneity of blood cancers.
MentLife, Drug Discovery, Development & Trends, nov 6 2013
The document discusses trends in the pharmaceutical industry from the past to the present and future. It provides background on the speaker, Richard Cook, and his experience working in pharmaceutical research and development. It then covers the history and evolution of the industry, including major companies, mergers and acquisitions, key events, and the development process for new drugs. The challenges facing pharmaceutical research and development are also examined.
Epilepsy Drugs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Op...
The global epilepsy drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.16% during 2024-2032.
More Info:- https://www.imarcgroup.com/epilepsy-drugs-market
Global bispecific antibody market & clinical pipeline insight 2020
“Global Bispecific Antibody Market & Clinical Pipeline Insight 2020” Report Highlights:
Overview of Bispecific Antibody
Mechanism of Action of Bispecific Antibody
Design & Engineering of Bispecific Antibodies
Applications of Bispecific Antibodies
Global Bispecific Antibodies Clinical Pipeline by Company, Indication & Phase
Global Bispecific Antibodies Clinical Pipeline: 123 Bispecific Antibodies
Marketed Bispecific Antibodies: Blinatumomab (Blincyto) & Catumaxomab (Removab)
Bayer(benazir)
This document provides an overview of Bayer's global operations and sales figures by region for 2009. It also summarizes the sales and R&D expenditures of Bayer's main divisions: CropScience, MaterialScience, and HealthCare. HealthCare had the highest sales at 15.9 billion Euros in 2009 and is divided into Pharmaceuticals, Consumer Care, Medical Care, Animal Health, and Diagnostic Imaging. The document highlights some of Bayer's major pipeline drugs and diagnostic imaging technologies in development.
AI Driven Emotional Recognition in Digital Ads - Tarun Gupta
AI Driven Emotional Recognition in Digital Ads - Tarun GuptaDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
This session will aim to comprehensively review the current state of artificial intelligence techniques for emotional recognition and their potential applications in optimizing digital advertising strategies. Key studies developing AI models for multimodal emotion recognition from videos, images, and neurophysiological signals were analyzed to build content for this session. The session delves deeper into the current challenges, opportunities to help realize the full benefits of emotion AI for personalized digital marketing.No Cookies, No Problem - Steve Krull, Be Found Online
No Cookies, No Problem - Steve Krull, Be Found OnlineDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
In the face of the news of Google beginning to remove cookies from Chrome (30m users at the time of writing), there’s no longer time for marketers to throw their hands up and say “I didn’t know” or “They won’t go through with it”. Reality check - it has already begun - the time to take action is now. The good news is that there are solutions available and ready for adoption… but for many the race to catch up to the modern internet risks being a messy, confusing scramble to get back to "normal"Unleash the Power of Storytelling - Win Hearts, Change Minds, Get Results - R...
Unleash the Power of Storytelling - Win Hearts, Change Minds, Get Results - R...DigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Lily Ray - Optimize the Forest, Not the Trees: Move Beyond SEO Checklist - Mo...
Lily Ray, Vice President of SEO Strategy & Research at Amsive, explores optimizing strategies for sustainable growth and explores the impact of AI on the SEO landscape.
Influencer Marketing Master Class - Alexis Andreasik
Influencer Marketing Master Class - Alexis AndreasikDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Empowering Influencers: The New Center of Brand-Consumer Dynamics
In the current market landscape, establishing genuine connections with consumers is crucial. This presentation, "Empowering Influencers: The New Center of Brand-Consumer Dynamics," explores how influencers have become pivotal in shaping brand-consumer relationships. We will examine the strategic use of influencers to create authentic, engaging narratives that resonate deeply with target audiences, driving success in the evolved purchase funnel.WTS-Berlin-2024-Veronika-Höller-Innovate-NextGEN-SEO-Merging-AI-Multimedia-an...
Dive deep into the cutting-edge strategies we're employing to revolutionize our web presence in the age of AI-driven search. As Gen Z reshapes the digital realm, discover how we can bridge the generational divide. Unlock the synergistic power of PPC, social media, and SEO, driving unparalleled revenues for our projects.
More Related Content
Similar to Pharma Marketing.pptx
Top 10 biotech companies & market share 2008
The biotech market grew 12.5% in 2007, twice as fast as the pharmaceutical market. The top 10 biotech companies comprised $61.4 billion in sales, or over 10% of the $712 billion prescription drug market. Amgen was the largest biotech company, with $15.9 billion in sales and blockbuster drugs like Enbrel. Amgen and other top companies like Roche/Genentech, Johnson & Johnson, and Novo Nordisk have several blockbuster drugs on the market and are developing new therapies, with many awaiting FDA approval.
‘Orphan drugs’ future growth potential for indian pharmaceutical market
This document discusses orphan drugs and their potential in the Indian pharmaceutical market. It defines orphan drugs as those developed for rare diseases affecting less than 8% of the population. The US was the first to pass orphan drug legislation in 1983 to incentivize development of these drugs. Similar laws now exist in other countries and provide benefits like 7 years of market exclusivity. While initially developed for small populations, some orphan drugs like Rituxan have become very profitable blockbusters. The global orphan drug market was worth $50 billion in 2011 and is growing faster than other drug markets. Several Indian companies are now developing or manufacturing orphan drugs for rare diseases.
Pharmaceutical Marketing
The document provides an overview of the global and Indian pharmaceutical industries and pharmaceutical marketing. It discusses how pharmaceutical companies research and develop new drugs, the large market size and top companies globally and in India, India's role as a major exporter of generic drugs, and common marketing strategies used in India's prescription-driven branded generic market, which involve establishing relationships with doctors who are the key decision-makers through regular visits and promotion by marketing representatives.
Global antibody drug conjugate market & pipeline insight2020
" Global Antibody Drug Conjugate Market & Pipeline Insight 2020" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
Download Global antibody drug conjugate market & pipeline insight2020
\" Global Antibody Drug Conjugate Market & Pipeline Insight 2020\" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
GDHC118PIDR_Peripheral Artery Disease_sample
This document provides a summary and analysis of the global peripheral artery disease (PAD) drug market from 2014-2024. Some key points:
- The global PAD drug market was worth $543.4 million in 2014 and is projected to reach $816.3 million by 2024, a compound annual growth rate of 4.15%.
- The US and China are expected to experience the strongest growth in market share, while markets in the EU and Japan will remain stagnant or contract.
- Promising late-stage pipeline drugs like Xarelto, Brilinta, and Zontivity have the potential to significantly impact the market but will face competition from cheaper generics after losing exclusivity during the forecast
Cardiac Market Outlook - 2016 by Nitesh bhele
Cardiac Market Outlook - 2016 by Nitesh bhele
Nitesh Bhele - Marketer, Writer | Healthcare & Pharmaceutical Industry
India and global generics M&A Summary 2007
This document provides a summary of mergers and acquisitions (M&A) deals in the global and Indian generics industries from 2007 and an outlook for 2007-2010. It finds that the generics market is growing faster than the branded drug market. Both large non-Indian and Indian generic companies are pursuing M&A deals to gain market share and access new markets. Transaction sizes for non-Indian deals were in the hundreds of millions to billions, while Indian deals were typically in the high millions. The outlook for Indian generics companies remains strong, though profitability challenges exist from funding large deals and global integration.
Bio similar- An opportunities or challenge for Indian Company
1. The global biosimilars market is expected to grow significantly in the coming years due to various drivers such as patent expiries of major biologics and increasing cost containment pressures.
2. Indian companies are well positioned in the biosimilars space due to their established low-cost manufacturing capabilities and expertise in biologics. Key players in India include Dr. Reddy's, Biocon, Cipla and Intas.
3. Developing biosimilars presents several challenges including high development costs, complex clinical trials and unclear regulatory guidelines. Indian companies strategy involves partnerships for cost-effective development and leveraging domestic capabilities and emerging markets for growth.
Shivai Gupta - POSTER
Orphan drugs are pharmaceutical agents that treat rare diseases or conditions affecting less than 200,000 people in the United States. The Orphan Drug Act provides incentives for developing these drugs, including 7 years of market exclusivity and tax credits. Since its passage, over 3,600 orphan drugs have been designated. By 2020, orphan drugs are projected to make up 20.2% of worldwide prescription drug sales due to their high prices and lack of alternatives for patients.
Us blood cancer drug market & pipeline analysis 2015
"US Blood Cancer Drug Market & Pipeline Analysis 2015" Report Highlights:
Blood Cancer Incidence & Prevalence
Blood Cancer Drug Market Overview
Blood Cancer Drug Market Dynamics
Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline Insight
Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline: 435 Drugs
Majority Drugs in Phase-I Clinical Trials: 128 Drugs
Marketed Leukemia, Lymphoma & Myeloma Drug Clinical & Patent Analysis
Marketed Leukemia, Lymphoma & Myeloma Drug: 48 Drugs
Download Us blood cancer drug market & pipeline analysis 2015
US pharmaceutical companies have identified opportunities to generate significant revenues from treating blood cancers in the US market. The number of blood cancer cases is rising, and demand exists for improved therapies. As a result, many new drugs have been introduced for treating blood cancers. Several innovative therapies are in clinical trials that could be approved in coming years. Key drug classes for treating blood cancers include chemotherapy drugs, monoclonal antibodies, and tyrosine kinase inhibitors, which have shown better outcomes than chemotherapy alone. The future blood cancer drug market is expected to grow as more innovative therapies enter the market, though developing treatments remains challenging due to the heterogeneity of blood cancers.
MentLife, Drug Discovery, Development & Trends, nov 6 2013
The document discusses trends in the pharmaceutical industry from the past to the present and future. It provides background on the speaker, Richard Cook, and his experience working in pharmaceutical research and development. It then covers the history and evolution of the industry, including major companies, mergers and acquisitions, key events, and the development process for new drugs. The challenges facing pharmaceutical research and development are also examined.
Epilepsy Drugs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Op...
The global epilepsy drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.16% during 2024-2032.
More Info:- https://www.imarcgroup.com/epilepsy-drugs-market
Global bispecific antibody market & clinical pipeline insight 2020
“Global Bispecific Antibody Market & Clinical Pipeline Insight 2020” Report Highlights:
Overview of Bispecific Antibody
Mechanism of Action of Bispecific Antibody
Design & Engineering of Bispecific Antibodies
Applications of Bispecific Antibodies
Global Bispecific Antibodies Clinical Pipeline by Company, Indication & Phase
Global Bispecific Antibodies Clinical Pipeline: 123 Bispecific Antibodies
Marketed Bispecific Antibodies: Blinatumomab (Blincyto) & Catumaxomab (Removab)
Bayer(benazir)
This document provides an overview of Bayer's global operations and sales figures by region for 2009. It also summarizes the sales and R&D expenditures of Bayer's main divisions: CropScience, MaterialScience, and HealthCare. HealthCare had the highest sales at 15.9 billion Euros in 2009 and is divided into Pharmaceuticals, Consumer Care, Medical Care, Animal Health, and Diagnostic Imaging. The document highlights some of Bayer's major pipeline drugs and diagnostic imaging technologies in development.
Similar to Pharma Marketing.pptx (16)
‘Orphan drugs’ future growth potential for indian pharmaceutical market
‘Orphan drugs’ future growth potential for indian pharmaceutical market
Global antibody drug conjugate market & pipeline insight2020
Global antibody drug conjugate market & pipeline insight2020
Download Global antibody drug conjugate market & pipeline insight2020
Download Global antibody drug conjugate market & pipeline insight2020
Bio similar- An opportunities or challenge for Indian Company
Bio similar- An opportunities or challenge for Indian Company
Us blood cancer drug market & pipeline analysis 2015
Us blood cancer drug market & pipeline analysis 2015
Download Us blood cancer drug market & pipeline analysis 2015
Download Us blood cancer drug market & pipeline analysis 2015
MentLife, Drug Discovery, Development & Trends, nov 6 2013
MentLife, Drug Discovery, Development & Trends, nov 6 2013
Epilepsy Drugs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Op...
Epilepsy Drugs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Op...
Global bispecific antibody market & clinical pipeline insight 2020
Global bispecific antibody market & clinical pipeline insight 2020
Recently uploaded
AI Driven Emotional Recognition in Digital Ads - Tarun Gupta
AI Driven Emotional Recognition in Digital Ads - Tarun GuptaDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
This session will aim to comprehensively review the current state of artificial intelligence techniques for emotional recognition and their potential applications in optimizing digital advertising strategies. Key studies developing AI models for multimodal emotion recognition from videos, images, and neurophysiological signals were analyzed to build content for this session. The session delves deeper into the current challenges, opportunities to help realize the full benefits of emotion AI for personalized digital marketing.No Cookies, No Problem - Steve Krull, Be Found Online
No Cookies, No Problem - Steve Krull, Be Found OnlineDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
In the face of the news of Google beginning to remove cookies from Chrome (30m users at the time of writing), there’s no longer time for marketers to throw their hands up and say “I didn’t know” or “They won’t go through with it”. Reality check - it has already begun - the time to take action is now. The good news is that there are solutions available and ready for adoption… but for many the race to catch up to the modern internet risks being a messy, confusing scramble to get back to "normal"Unleash the Power of Storytelling - Win Hearts, Change Minds, Get Results - R...
Unleash the Power of Storytelling - Win Hearts, Change Minds, Get Results - R...DigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Lily Ray - Optimize the Forest, Not the Trees: Move Beyond SEO Checklist - Mo...
Lily Ray, Vice President of SEO Strategy & Research at Amsive, explores optimizing strategies for sustainable growth and explores the impact of AI on the SEO landscape.
Influencer Marketing Master Class - Alexis Andreasik
Influencer Marketing Master Class - Alexis AndreasikDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Empowering Influencers: The New Center of Brand-Consumer Dynamics
In the current market landscape, establishing genuine connections with consumers is crucial. This presentation, "Empowering Influencers: The New Center of Brand-Consumer Dynamics," explores how influencers have become pivotal in shaping brand-consumer relationships. We will examine the strategic use of influencers to create authentic, engaging narratives that resonate deeply with target audiences, driving success in the evolved purchase funnel.WTS-Berlin-2024-Veronika-Höller-Innovate-NextGEN-SEO-Merging-AI-Multimedia-an...
Dive deep into the cutting-edge strategies we're employing to revolutionize our web presence in the age of AI-driven search. As Gen Z reshapes the digital realm, discover how we can bridge the generational divide. Unlock the synergistic power of PPC, social media, and SEO, driving unparalleled revenues for our projects.
Digital Marketing Trends - Experts Insights on How to Gain a Competitive Edge...
Digital Marketing Trends - Experts Insights on How to Gain a Competitive Edge...DigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
The digital marketing industry is changing faster than ever and those who don’t adapt with the times are losing market share. Where should marketers be focusing their efforts? What strategies are the experts seeing get the best results? Get up-to-speed with the latest industry insights, trends and predictions for the future in this panel discussion with some leading digital marketing experts.Pillar-Based Marketing Master Class - Ryan Brock
Pillar-Based Marketing Master Class - Ryan BrockDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
In this humorous and data-heavy Master Class, join us in a joyous celebration of life honoring the long list of SEO tactics and concepts we lost this year. Remember fondly the beautiful time you shared with defunct ideas like link building, keyword cannibalization, search volume as a value indicator, and even our most cherished of friends: the funnel. Make peace with their loss as you embrace a new paradigm for organic content: Pillar-Based Marketing. Along the way, discover that the results that old SEO and all its trappings brought you weren’t really very good at all, actually.
In this respectful and life-affirming service—erm, session—join Ryan Brock (Chief Solution Officer at DemandJump and author of Pillar-Based Marketing: A Data-Driven Methodology for SEO and Content that Actually Works) and leave with:
• Clear and compelling evidence that most legacy SEO metrics and tactics have slim to no impact on SEO outcomes
• A major mindset shift that eliminates most of the metrics and tactics associated with SEO in favor of a single metric that defines and drives organic ranking success
• Practical, step-by-step methodology for choosing SEO pillar topics and publishing content quickly that ranks fastCrafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...
Crafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...DigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Customer Experience is not only for B2C and big box brands. Embark on a transformative journey into the realm of B2B customer experience with our masterclass. In this dynamic session, we'll delve into the intricacies of designing and implementing seamless customer journeys that leave a lasting impression. Explore proven strategies and best practices tailored specifically for the B2B landscape, learning how to navigate complex decision-making processes and cultivate meaningful relationships with clients. From initial engagement to post-sale support, discover how to optimize every touchpoint to deliver exceptional experiences that drive loyalty and revenue growth. Join us and unlock the keys to unparalleled success in the B2B arena.
Key Takeaways:
1. Identify your customer journey and growth areas
2. Build a three-step customer experience strategy
3. Put your CX data to use and drive action in your organizationMastering The Best Restaurant Advertising Campaigns Detailed Guide
A guide for making the Best Restaurant Advertising Campaigns with demographics, data analytics, and digital advertising for measurable results.
Gokila digital marketing| consultant| Coimbatore
Myself Gokila digital marketing consultant located in Coimbatore other various types of digital marketing services such as SEM
SEO SMO SMM CAMPAIGNS content writing web design for all your business needs with affordable cost
Digital Marketing Services | Techvolt Software :
Digital Marketing is a latest method of Marketing techniques widely used across the Globe. Digital Marketing is an online marketing technique and methods used for all products and services through Search Engine and Social media advertisements. Previously the marketing techniques were used without using the internet via direct and indirect marketing strategies such as advertising through Telemarketing,Newspapers,Televisions,Posters etc.
List of Services offered in Digital Marketing |Techvolt Software :
Techvolt Software offers best Digital Marketing services for promoting your products and services through online platform on the below methods of Digital marketing
1. Search Engine Optimization (SEO)
2. Search Engine Marketing (SEM)
3. Social Media Optimization (SMO)
4. Social Media Marketing (SMM)
5. Campaigns
Importance | Need of Digital Marketing (Online Promotions) :
1. Quick Promotions through Online
2. Generation of More leads and Business Enquiries via Search Engine and Social Media Platform
3. Latest Technology development vs Business promotions
4. Creation of Social Branding
5. Promotion with less investment
Benefits Digital Marketing Services at Techvolt software :
1. Services offered with Affordable cost
2. Free Content writing
3. Free Dynamic Website design*
4. Best combo offers on website Hosting,design along with digital marketing services
5. Assured Lead Generation through Search Engine and Social Media
6. Online Maintenance Support
Free Website + Digital Marketing Services
Techvolt Software offers Free website design for all customer and clients who is availing the digital marketing services for a minimum period of 6 months.
With Regards
Gokila digital marketer
Coimbatore
From Subreddits To Search: Maximizing Your Brand's Impact On Reddit
The search landscape is undergoing a seismic shift, and Reddit is at the epicenter. Google's Helpful Content Update and its $60 million deal with Reddit, coupled with OpenAI's partnership, have catapulted Reddit's real-time content to unprecedented heights.
Check out this insightful webinar exploring the newfound importance of Reddit in the digital marketing landscape. Learn how these changes make Reddit an essential platform for getting your brand and content in front of evolving search audiences.
You’ll hear:
- The evolution of Reddit as a major influencer on SERPS over the years.
- The impact of recent changes and partnerships on Reddit’s place in search.
- A comprehensive look at Reddit, how it works, and how to approach it.
- Unique engagement opportunities presented by Reddit.
With Brent Csutoras, a Reddit expert with over 18 years of experience on the platform, we’ll delve into the intricacies of Reddit's communities, known as Subreddits, and how to leverage their power without compromising authenticity or violating community guidelines in the age of AI-driven search experiences.
Don't miss this opportunity to stay ahead of the curve and leverage Reddit for your brand's success.
PickUp_conversational AI_Capex, Inc._20240611
PickUp, Improve conversions with scenario-based conversational AI.
From Hope to Despair The Top 10 Reasons Businesses Ditch SEO Tactics.pptx
From Hope to Despair: The Top 10 Reasons Businesses Ditch SEO Tactics
Are you tired of seeing your business's online visibility plummet from hope to despair? When it comes to SEO tactics, many businesses find themselves grappling with challenges that lead them to abandon their strategies altogether. In a digital landscape that's constantly evolving, staying on top of SEO best practices is crucial to maintaining a competitive edge.
In this blog, we delve deep into the top 10 reasons why businesses ditch SEO tactics, uncovering the pain points that may resonate with you:
1. Algorithm Changes: The ever-changing algorithms can leave businesses feeling like they're chasing a moving target. Search engines like Google frequently update their algorithms to improve user experience and provide more relevant search results. However, these updates can significantly impact your website's visibility and ranking if you're not prepared.
2. Lack of Results: Investing time and resources without seeing tangible results can be disheartening. The absence of immediate results often leads businesses to lose faith in their SEO strategies. It's important to remember that SEO is a long-term game that requires patience and consistent effort.
3. Technical Challenges: From site speed issues to complex metadata implementation, technical hurdles can be daunting. Overcoming these challenges is crucial for SEO success, as technical issues can hinder your website's performance and user experience.
4. Keyword Competition: Fierce competition for top keywords can make it hard to rank effectively. Businesses often struggle to find the right balance between targeting high-traffic keywords and finding less competitive, niche keywords that can still drive significant traffic.
5. Lack of Understanding of SEO Basics: Many businesses dive into the complex world of SEO without fully grasping the fundamental principles. This lack of understanding can lead to several issues:
Keyword Awareness: Failing to recognize the importance of keyword research and targeting the right keywords in content.
On-Page Optimization: Ignorance regarding crucial on-page elements such as meta tags, headers, and content structure.
Technical SEO Best Practices: Overlooking essential aspects like site speed, mobile responsiveness, and crawlability.
Backlinks: Not understanding the value of high-quality backlinks from reputable sources.
Analytics: Failing to track and analyze data prevents businesses from optimizing their SEO efforts effectively.
6. Unrealistic Expectations and Timeframe: Entrepreneurs often fall prey to the allure of quick fixes and overnight success. Unrealistic expectations can overshadow the reality of the time and effort needed to see tangible results in the highly competitive digital landscape. SEO is a long-term strategy, and setting realistic goals is crucial for success.
#SEO #DigitalMarketing #BusinessGrowth #OnlineVisibility #SEOChallenges #BostonSEO
Podcast, The New Marketing Currency - Ozeal Debastos
Podcast, The New Marketing Currency - Ozeal DebastosDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Journey of amplification and buzz creation through podcast marketing, appealing to brands and marketers looking to expand their reach.Etsy Marketing Guide - Tips For Selling Digital Products
This guide is for those who are selling digital products on Etsy platform.
SEO in the AI Era - Trust, Quality and Content Discovery - Andy Crestodina
SEO in the AI Era - Trust, Quality and Content Discovery - Andy CrestodinaDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
We’ve entered a new era in digital. Search and AI are colliding, in more ways than one. And they all have major implications for marketers.
• SEOs now use AI to optimize content.
• Google now uses AI to generate answers.
• Users are skipping search completely. They can now use AI to get answers. So AI has changed everything …or maybe not. Our audience hasn’t changed. Their information needs haven’t changed. Their perception of quality hasn’t changed. In reality, the most important things haven’t changed at all. In this session, you’ll learn the impact of AI. And you’ll learn ways that AI can make us better at the classic challenges: getting discovered, connecting through content and staying top of mind with the people who matter most. We’ll use timely tools to rebuild timeless foundations. We’ll do better basics, but with the most advanced techniques. Andy will share a set of frameworks, prompts and techniques for better digital basics, using the latest tools of today. And in the end, Andy will consider - in a brief glimpse - what might be the biggest change of all, and how to expand your footprint in the new digital landscape.
Key Takeaways:
How to use AI to optimize your content
How to find topics that algorithms love
How to get AI to mention your content and your brandFuture-Proof Like Beyoncé - Syncing Email and Social Media for Iconic Brand L...
Future-Proof Like Beyoncé - Syncing Email and Social Media for Iconic Brand L...DigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
In this dynamic session titled "Future-Proof Like Beyoncé: Syncing Email and Social Media for Iconic Brand Longevity," Carlos Gil, U.S. Brand Evangelist for GetResponse, unveils how to safeguard and elevate your digital marketing strategy. Explore how integrating email marketing with social media can not only increase your brand's reach but also secure its future in the ever-changing digital landscape. Carlos will share invaluable insights on developing a robust email list, leveraging data integration for targeted campaigns, and implementing AI tools to enhance cross-platform engagement. Attendees will learn how to maintain a consistent brand voice across all channels and adapt to platform changes proactively. This session is essential for marketers aiming to diversify their online presence and minimize dependence on any single platform. Join Carlos to discover how to turn social media followers into loyal email subscribers and ultimately, drive sustainable growth and revenue for your brand. By harnessing the best practices and innovative strategies discussed, you will be equipped to navigate the challenges of the digital age, ensuring your brand remains relevant and resonant with your audience, no matter the platform. Don’t miss this opportunity to transform your approach and achieve iconic brand longevity akin to Beyoncé's enduring influence in the entertainment industry.
Key Takeaways:
Integration of Email and Social Media: Understanding how to seamlessly integrate email marketing with social media efforts to expand reach and reinforce brand presence. Building a Robust Email List: Strategies for developing a strong email list that provides a direct line of communication to your audience, independent of social media algorithms. Data Integration for Targeted Campaigns: Leveraging combined data from email and social media to create personalized, targeted marketing campaigns that resonate with the audience. Utilization of AI Tools: Implementing AI and automation tools to enhance efficiency and effectiveness across marketing channels. Consistent Brand Voice Across Platforms: Maintaining a unified brand voice and message across all digital platforms to strengthen brand identity and user trust. Proactive Adaptation to Platform Changes: Staying ahead of social media platform changes and algorithm updates to keep engagement high and interactions meaningful. Conversion of Social Followers to Email Subscribers: Techniques to encourage social media followers to subscribe to email, ensuring a direct and consistent connection. Sustainable Growth and Minimized Platform Dependence: Strategies to diversify digital presence and reduce reliance on any single social media platform, thereby mitigating risks associated with platform volatility.Efficient Website Management for Digital Marketing Pros
Learn how to optimize website projects, leverage SEO tactics effectively, and implement product-led marketing approaches for enhanced digital presence and ROI.
This session is your key to unlocking the secrets of successful digital marketing campaigns and maximizing your business's online potential.
Actionable tactics you can apply after this session:
- Streamlined Website Management: Discover techniques to streamline website development, manage day-to-day operations efficiently, and ensure smooth project execution.
- Effective SEO Practices: Gain valuable insights into optimizing your website for search engines, improving visibility, and driving organic traffic to your digital assets.
- Leverage Product-Led Marketing: Explore strategies for incorporating product-led marketing principles into your digital marketing efforts, enhancing user engagement and driving conversions.
Don't miss out on this opportunity to elevate your digital marketing game and achieve tangible results!
Breaking Silos To Break Bank: Shattering The Divide Between Search And Social
At Mozcon 2024 I shared this deck on bridging the divide between search and social. We began by acknowledging that search-first marketers are used to different rules of engagement than social marketers. We also looked at how both channels treat creative, audiences, bidding/budgeting, and AI. We finished by going through how they can win together including UTM audits, harvesting comments from both to inform creative, and allowing for non-login forums to be part of your marketing strategy.
I themed this deck using Baldur's Gate 3 characters: Gale as Search and Astarion as Social
Recently uploaded (20)
AI Driven Emotional Recognition in Digital Ads - Tarun Gupta
AI Driven Emotional Recognition in Digital Ads - Tarun Gupta
No Cookies, No Problem - Steve Krull, Be Found Online
No Cookies, No Problem - Steve Krull, Be Found Online
Unleash the Power of Storytelling - Win Hearts, Change Minds, Get Results - R...
Unleash the Power of Storytelling - Win Hearts, Change Minds, Get Results - R...
Lily Ray - Optimize the Forest, Not the Trees: Move Beyond SEO Checklist - Mo...
Lily Ray - Optimize the Forest, Not the Trees: Move Beyond SEO Checklist - Mo...
Influencer Marketing Master Class - Alexis Andreasik
Influencer Marketing Master Class - Alexis Andreasik
WTS-Berlin-2024-Veronika-Höller-Innovate-NextGEN-SEO-Merging-AI-Multimedia-an...
WTS-Berlin-2024-Veronika-Höller-Innovate-NextGEN-SEO-Merging-AI-Multimedia-an...
Digital Marketing Trends - Experts Insights on How to Gain a Competitive Edge...
Digital Marketing Trends - Experts Insights on How to Gain a Competitive Edge...
Crafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...
Crafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...
Mastering The Best Restaurant Advertising Campaigns Detailed Guide
Mastering The Best Restaurant Advertising Campaigns Detailed Guide
From Subreddits To Search: Maximizing Your Brand's Impact On Reddit
From Subreddits To Search: Maximizing Your Brand's Impact On Reddit
From Hope to Despair The Top 10 Reasons Businesses Ditch SEO Tactics.pptx
From Hope to Despair The Top 10 Reasons Businesses Ditch SEO Tactics.pptx
Podcast, The New Marketing Currency - Ozeal Debastos
Podcast, The New Marketing Currency - Ozeal Debastos
Etsy Marketing Guide - Tips For Selling Digital Products
Etsy Marketing Guide - Tips For Selling Digital Products
SEO in the AI Era - Trust, Quality and Content Discovery - Andy Crestodina
SEO in the AI Era - Trust, Quality and Content Discovery - Andy Crestodina
Future-Proof Like Beyoncé - Syncing Email and Social Media for Iconic Brand L...
Future-Proof Like Beyoncé - Syncing Email and Social Media for Iconic Brand L...
Efficient Website Management for Digital Marketing Pros
Efficient Website Management for Digital Marketing Pros
Breaking Silos To Break Bank: Shattering The Divide Between Search And Social
Breaking Silos To Break Bank: Shattering The Divide Between Search And Social
Pharma Marketing.pptx
- 2. Flow of Presentation • Top Pharmaceutical Brands • Global Pharmaceutical Market • Indian Pharmaceutical Market • Marketing • Pharmaceutical Brand Management • Brand Management for Pharmacy Colleges
- 5. Top 10 Pharma Brands- International Brand Company Molecule Indications Value (US $ Billions) Comirnaty Pfizer Vaccine Covid 36.9 Humira Abbvie Adalimumab For Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis 20.7 Spikevax Moderna Vaccine Covid 17.7 Keytruda Merck Pembrolizumab For treatment of Cancer 17.2 Revlimid BMS Lenalidomid For treatment of Cancer 12.8 Eliquis BMS Apixaban For prevention of stroke and systemic embolism 10.8 Stelara Janssen Ustekinumab For treatment of Crohn's disease, ulcerative colitis, plaque psoriasis & psoriatic arthritis 9.1 Biktarvy Gilead Bictegravir, Emtricitabine, Tenofovir For treatment of HIV 8.6 Opdivo BMS Nivolumab For treatment of Cancer 7.6 Trulicity Lilly Dulaglutide Antidiabetic 6.5
- 6. Global Pharmaceuticals Market • Global pharmaceuticals market is expected to be worth USD 1.57 trillion by 2023. • The reasons are simple: aging and growing population, rising income levels, and emerging medical conditions and emergence of new diseases.
- 10. Definition of Marketing “Exchanges between people in which something of value is traded for the purpose of satisfying needs and wants”
- 12. Misconceptions About Marketing • Marketing is selling or advertising. • Marketing is evil. • Health care professionals do not need to market. • Employee pharmacists do not need to market. • Only retail pharmacists need to market.
- 13. Functions of Marketing Department Brand Management /